• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
PROFILE PD: profile of function and impairment level experience with Parkinson disease--clinimetric properties of a rating scale for physical therapist practice.PD 简介:帕金森病的功能和损伤水平体验简介——物理治疗师实践评定量表的计量特性。
J Neurol Phys Ther. 2010 Dec;34(4):182-92. doi: 10.1097/NPT.0b013e3181fd1b8d.
2
Cross cultural adaptations and psychometric domains of Brazilian version of PROFILE PD for Parkinson's disease.帕金森病PROFILE PD巴西版本的跨文化适应与心理测量领域
Disabil Rehabil. 2017 Aug;39(17):1759-1770. doi: 10.1080/09638288.2016.1209695. Epub 2016 Aug 16.
3
Measuring disease progression in early Parkinson disease: the National Institutes of Health Exploratory Trials in Parkinson Disease (NET-PD) experience.早期帕金森病疾病进展的测量:美国国立卫生研究院帕金森病探索性试验(NET-PD)的经验。
JAMA Neurol. 2014 Jun;71(6):710-6. doi: 10.1001/jamaneurol.2014.391.
4
Test-retest reliability of the unified Parkinson's disease rating scale in patients with early Parkinson's disease: results from a multicenter clinical trial.早期帕金森病患者统一帕金森病评定量表的重测信度:一项多中心临床试验的结果
Mov Disord. 2002 Jul;17(4):758-63. doi: 10.1002/mds.10011.
5
Metric attributes of the unified Parkinson's disease rating scale 3.0 battery: part II, construct and content validity.统一帕金森病评定量表3.0套件的计量属性:第二部分,结构效度和内容效度。
Mov Disord. 2006 Nov;21(11):1892-8. doi: 10.1002/mds.21071.
6
Validation and cross-cultural adaptation of the Self-Assessment Disability Scale in patients with Parkinson's disease in Serbia.验证和跨文化适应自评残疾量表在塞尔维亚的帕金森病患者。
J Neurol. 2013 Aug;260(8):1970-7. doi: 10.1007/s00415-013-6906-2. Epub 2013 Apr 7.
7
Barthel Index and modified Rankin Scale: Psychometric properties during medication phases in idiopathic Parkinson disease.巴塞尔指数和改良兰金量表:特发性帕金森病药物治疗阶段的心理测量特性。
Ann Phys Rehabil Med. 2020 Nov;63(6):500-504. doi: 10.1016/j.rehab.2019.08.006. Epub 2019 Dec 6.
8
Unified Parkinson's Disease Rating Scale characteristics and structure. The Cooperative Multicentric Group.统一帕金森病评定量表的特征与结构。协作多中心研究组。
Mov Disord. 1994 Jan;9(1):76-83. doi: 10.1002/mds.870090112.
9
Reliability and validity of the Tinetti Mobility Test for individuals with Parkinson disease.帕金森病患者Tinetti平衡与步态测试的信度和效度
Phys Ther. 2007 Oct;87(10):1369-78. doi: 10.2522/ptj.20070007. Epub 2007 Aug 7.
10
Comparison between two functional mobility scales for Parkinson's disease directly applied to physical therapy practice: cross-cultural adaptation and measurement properties.两种帕金森病功能性移动性量表在物理治疗实践中的直接应用比较:跨文化调适和测量特性。
Eur J Phys Rehabil Med. 2017 Oct;53(5):664-675. doi: 10.23736/S1973-9087.16.04148-4. Epub 2016 Apr 6.

本文引用的文献

1
Movement Disorder Society-sponsored revision of the Unified Parkinson's Disease Rating Scale (MDS-UPDRS): scale presentation and clinimetric testing results.运动障碍协会赞助的统一帕金森病评定量表修订版(MDS-UPDRS):量表介绍及临床测量测试结果
Mov Disord. 2008 Nov 15;23(15):2129-70. doi: 10.1002/mds.22340.
2
Intraclass correlations: uses in assessing rater reliability.组内相关系数:在评估评分者可靠性中的应用。
Psychol Bull. 1979 Mar;86(2):420-8. doi: 10.1037//0033-2909.86.2.420.
3
Movement Disorder Society-sponsored revision of the Unified Parkinson's Disease Rating Scale (MDS-UPDRS): Process, format, and clinimetric testing plan.运动障碍协会赞助的统一帕金森病评定量表修订版(MDS-UPDRS):过程、格式及临床测量测试计划。
Mov Disord. 2007 Jan;22(1):41-7. doi: 10.1002/mds.21198.
4
A method for evaluating disability in patients with Parkinson's disease.一种评估帕金森病患者残疾程度的方法。
J Nerv Ment Dis. 1961 Aug;133:143-7. doi: 10.1097/00005053-196108000-00010.
5
The Unified Parkinson's Disease Rating Scale (UPDRS): status and recommendations.统一帕金森病评定量表(UPDRS):现状与建议
Mov Disord. 2003 Jul;18(7):738-50. doi: 10.1002/mds.10473.
6
Systematic evaluation of rating scales for impairment and disability in Parkinson's disease.帕金森病功能障碍和残疾评定量表的系统评价
Mov Disord. 2002 Sep;17(5):867-76. doi: 10.1002/mds.10248.
7
Test-retest reliability of the unified Parkinson's disease rating scale in patients with early Parkinson's disease: results from a multicenter clinical trial.早期帕金森病患者统一帕金森病评定量表的重测信度:一项多中心临床试验的结果
Mov Disord. 2002 Jul;17(4):758-63. doi: 10.1002/mds.10011.
8
Development of a clinical rating scale for persons with Parkinson's disease.帕金森病患者临床评定量表的研制
J Am Geriatr Soc. 1999 Jun;47(6):763-4. doi: 10.1111/j.1532-5415.1999.tb01608.x.
9
Exercise: effects on physical functional performance in independent older adults.运动:对独立生活的老年人身体功能表现的影响
J Gerontol A Biol Sci Med Sci. 1999 May;54(5):M242-8. doi: 10.1093/gerona/54.5.m242.
10
Continuous-scale physical functional performance in healthy older adults: a validation study.健康老年人的连续量表身体功能表现:一项验证研究。
Arch Phys Med Rehabil. 1996 Dec;77(12):1243-50. doi: 10.1016/s0003-9993(96)90187-2.

PD 简介:帕金森病的功能和损伤水平体验简介——物理治疗师实践评定量表的计量特性。

PROFILE PD: profile of function and impairment level experience with Parkinson disease--clinimetric properties of a rating scale for physical therapist practice.

机构信息

Department of Physical Medicine and Rehabilitation, Physical Therapy Program, University of Colorado Denver, Aurora, Colorado 80045, USA.

出版信息

J Neurol Phys Ther. 2010 Dec;34(4):182-92. doi: 10.1097/NPT.0b013e3181fd1b8d.

DOI:10.1097/NPT.0b013e3181fd1b8d
PMID:21084919
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3014090/
Abstract

BACKGROUND AND PURPOSE

Individuals with Parkinson disease (PD) experience a range of deficits of body systems and activities. A clinical test is needed that is reliable, valid, applicable to physical therapist practice, and appropriate for use in early and mid-stages of the disease. PROFILE PD is one such scale, consisting of 24 items that would typically be assessed during the physical therapist's examination and evaluation of individuals with PD. The purpose of this article is to report on clinimetric properties of the PROFILE PD and to make the test available for use.

METHODS

Interrater reliability was determined using the intraclass correlation coefficient. Construct validity was determined by comparing scores on the PROFILE PD with the gold standard (Unified Parkinson's Disease Rating Scale [UPDRS]) as well as scales of physical activity and participation. Construct validity and structure of the PROFILE PD were further examined using exploratory factor analysis using principal component analysis with Promax rotation that allows a correlated factor structure.

RESULTS

Interrater reliability of the PROFILE PD was high (ICC = 0.97). Construct validity was demonstrated with the UPDRS (r = 0.86, P < 0.0001), Schwab & England Activities of Daily Living Scale (S&E) (r = -0.83, P < 0.0001), and Continuous Scale Physical Functional Performance test (r = -0.62, P < 0.0001). Principal component analysis demonstrated that the test comprises a single scale.

CONCLUSIONS

The PROFILE PD is a reliable and valid scale that can be used to quantify alterations in body systems and activity of individuals in early and mid-stages of PD. Use of the scale can provide an overall summary of the impact of PD on body systems and activities.

摘要

背景与目的

帕金森病(PD)患者会出现一系列身体系统和活动的缺陷。需要一种可靠、有效、适用于物理治疗师实践、并适用于疾病早期和中期的临床测试。PROFILE PD 就是这样一种量表,由 24 个项目组成,通常在物理治疗师对 PD 患者进行检查和评估时进行评估。本文的目的是报告 PROFILE PD 的临床计量学特性,并使其可供使用。

方法

使用组内相关系数确定组内信度。通过将 PROFILE PD 的评分与金标准(统一帕金森病评定量表[UPDRS])以及身体活动和参与量表进行比较来确定结构效度。使用主成分分析和 Promax 旋转的探索性因子分析进一步检查 PROFILE PD 的结构效度和结构,允许相关因子结构。

结果

PROFILE PD 的组内信度很高(ICC = 0.97)。与 UPDRS(r = 0.86,P < 0.0001)、施瓦布和英格兰日常生活活动量表(S&E)(r = -0.83,P < 0.0001)和连续量表身体功能表现测试(r = -0.62,P < 0.0001)的相关性证明了结构效度。主成分分析表明,该测试由一个单一的量表组成。

结论

PROFILE PD 是一种可靠且有效的量表,可用于量化 PD 早期和中期个体身体系统和活动的改变。使用该量表可以提供 PD 对身体系统和活动影响的总体概述。